The common specifications for each of the groups of products listed in Annex XVI shall address, at least, application of risk management as set out in Annex I for the group of products in question and, where necessary, clinical evaluation regarding safety.
Leis na sonraíochtaí comhchoiteanna le haghaidh gach ceann de na grúpaí táirgí a liostaítear in Iarscríbhinn XVI, tabharfar aghaidh, ar a laghad, ar chur i bhfeidhm an bhainistithe riosca mar a leagtar amach in Iarscríbhinn I le haghaidh an ghrúpa táirgí atá i gceist, agus i gcás inarb iomchuí, le haghaidh meastóireacht chliniciúil maidir le sábháilteacht.